Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: The University of Texas Southwestern Medical Center, University of Pisa, Azienda Ospedaliera Universitaria Pisana, Fudan University, Zhongshan Hospital, Kindai University, Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université Henri Poincaré, Tongji Hospital, Huazhong University of Science and Technology, Policlinica Metropolitana, Kyorin University, Johns Hopkins University, Hospital Angeles Clinica Londres, Virginia Commonwealth University Medical Center, Nihon University, Catholic University of Korea, University of California, San Francisco
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2280586512